M
Myovant Sciences, Inc.
MYOVHealth Care· Basel, Switzerland
LAYOFFS TRACKED
1
LAST EVENT
Jun 30, 2023
MARKET CAP
—
EMPLOYEES
22
Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for women's health and endocrine diseases, including treatments for uterine fibroids, endometriosis, and prostate cancer. The company develops novel small molecule therapeutics and has strategic collaborations to advance its pipeline.
Layoff timeline
1 EVENTStories from here
No one has shared a story from Myovant Sciences yet. Went through a layoff here? Your experience helps others feel less alone.
Share your story →Get alerts for Myovant Sciences
We'll email you the moment a new layoff is reported here.